Skip to content

Non-Antibiotic Antimicrobial for Treatment of Respiratory Infections

A suite of antimicrobials with a novel mechanism of action to treat COVID-19 associated secondary infections

Published: 8th April 2020
Non-Antibiotic Antimicrobial for Treatment of Respiratory Infections
Christoph Burgstedt, stock.adobe.com
Patents
  • The underlying technologies are protected by a suite of patent families. These include granted patents in several jurisdictions (EPO, China, Australia, New Zealand), with pending applications in several other jurisdictions, including US and Japan.
IP Status
  • Patent application submitted
  • Patented
Seeking
  • Licensing
  • Development partner